Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000621834 | SCV000736736 | uncertain significance | Cardiovascular phenotype | 2017-01-04 | criteria provided, single submitter | clinical testing | The p.R10222C variant (also known as c.30664C>T), located in coding exon 123 of the TTN gene, results from a C to T substitution at nucleotide position 30664. The arginine at codon 10222 is replaced by cysteine, an amino acid with highly dissimilar properties, and is located in the A-band region of the N2-B isoform of the titin protein. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV004791629 | SCV005413072 | uncertain significance | not provided | 2024-08-21 | criteria provided, single submitter | clinical testing |